{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:07:25Z","timestamp":1793156845374,"version":"4.5.0"},"reference-count":124,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Coumarin is an oxygen-containing compound in medicinal chemistry. Coumarin\nplays an important role in both natural systems like plants and synthetic medicinal applications\nas drug molecules. Many structurally different coumarin compounds have been found to possess a\nwide range of similarities with the vital molecular targets in terms of their pharmacological action and\nsmall modifications in their structures, resulting in significant changes in their biological activities.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This review provides detailed information regarding the studies focused on the recent advances\nin various pharmacological aspects of coumarins.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>Various oxygen-containing heterocyclic compounds represent remarkable biological significance.\nThe fused aromatic oxygen-heterocyclic nucleus can change its electron density, thus altering\nthe chemical, physical and biological properties, respectively, due to its multiple binding modes with\nthe receptors, which play a crucial role in the pharmacological screening of drugs. Several heterocyclic\ncompounds have been synthesized which have their nuclei derived from various plants and animals.\nIn coumarins, the benzene ring is fused with a pyrone nucleus which provides stability to the\nnucleus. Coumarins have shown a wide range of pharmacological activities, such as anti-tumor, anticoagulant,\nanti-inflammatory, anti-oxidant, antiviral, antimalarial, anti-HIV, antimicrobial, etc.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Reactive oxygen species, like superoxide anion, hydroxyl radical, and hydrogen peroxide, are\na type of unstable molecule containing oxygen, which reacts with other molecules in the cell during\nmetabolism; however, when the number of reactive oxygen species increases, it may lead to cytotoxicity,\nthereby damaging the biological macromolecules. Hydroxyl Radical (OH) is a strong oxidizing\nagent and it is responsible for the cytotoxicity caused by oxygen in different plants, animals, and other\nmicrobes. Coumarin is the oldest and effective compound having antimicrobial, anti-inflammatory,\nantioxidant, antidepressant, analgesic, anticonvulsant activities, etc. Naturally existing coumarin compounds\nact against SARS-CoV-2 by preventing viral replication and targeting the active site against\nthe Mpro target protein.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This review highlights the different biological activities of coumarin derivatives. In this\nreview, we provide an updated summary of the researches which are related to recent advances in biological\nactivities of coumarins analogs and their most recent activities against COVID -19. Natural\ncompounds act as a rich resource for novel drug development against various SARS-CoV-2 viral\nstrains and viruses, like herpes simplex virus, influenza virus, human immunodeficiency virus, hepatitis\nB and C viruses, middle east respiratory syndrome, and severe acute respiratory syndrome.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557521666211116120823","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T04:43:25Z","timestamp":1637124205000},"page":"1314-1330","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Therapeutic Journey and Recent Advances in the Synthesis of Coumarin\nDerivatives"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3367-9836","authenticated-orcid":true,"given":"Shweta","family":"Sinha","sequence":"first","affiliation":[{"name":"Goel Institute of Pharmaceutical Sciences, Lucknow 226028 (U.P.), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4343-1957","authenticated-orcid":true,"given":"Kuldeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Integral University, Kursi Road, Lucknow 226026 (U.P.), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8487-3885","authenticated-orcid":true,"given":"Akash","family":"Ved","sequence":"additional","affiliation":[{"name":"Goel Institute of Pharmaceutical Sciences, Lucknow 226028 (U.P.), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-2688","authenticated-orcid":true,"given":"Syed Misbahul","family":"Hasan","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Integral University, Kursi Road, Lucknow 226026 (U.P.), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8106-4003","authenticated-orcid":true,"given":"Samar","family":"Mujeeb","sequence":"additional","affiliation":[{"name":"Hygia Institute of Pharmaceutical Education and Research, Lucknow,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejmech.2016.07.056","volume":"123","author":"Hassan M.Z.","year":"2016","unstructured":"Hassan M.Z.; Osman H.; Ali M.A.; Ahsan M.J.J.; Therapeutic potential of coumarins as antiviral agents. Eur J Med Chem 2016,123,236-255","journal-title":"Eur J Med Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"963248","DOI":"10.1155\/2013\/963248","volume":"2013","author":"Venugopala K.N.","year":"2013","unstructured":"Venugopala K.N.; Rashmi V.; Odhav B.; Review on natural coumarin lead compounds for their pharmacological activity. BioMed Res Int 2013,2013,963248","journal-title":"BioMed Res Int"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/14756360500323022","volume":"21","author":"Kontogiorgis C.A.","year":"2006","unstructured":"Kontogiorgis C.A.; Savvoglou K.; Hadjipavlou-Litina D.J.; Antiinflammatory and antioxidant evaluation of novel coumarin derivatives. J Enzyme Inhib Med Chem 2006,21(1),21-29","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2174\/1568026615666150220112437","volume":"15","author":"Najmanov\u00e1 I.","year":"2015","unstructured":"Najmanov\u00e1 I.; Dosed\u011bl M.; Hrdina R.; Anzenbacher P.; Filipsk\u00fd T.; \u0158\u00edha M.; Mlad\u011bnka P.; Cardiovascular effects of coumarins besides their antioxidant activity. Curr Top Med Chem 2015,15(9),830-849","journal-title":"Curr Top Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1021\/acschemneuro.8b00011","volume":"9","author":"Skalicka-Wozniak K.","year":"2018","unstructured":"Skalicka-Wozniak K.; Budzynska B.; Biala G.; Boguszewska-Czubara A.; Boguszewska-Czubara. Scopolamine-induced memory impairment is alleviated by xanthotoxin: Role of acetylcholinesterase and oxidative stress processes. ACS Chem Neurosci 2018,9(5),1184-1194","journal-title":"ACS Chem Neurosci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4172\/2157-7544.1000130","volume":"5","author":"Rohini K.","year":"2014","unstructured":"Rohini K.; Srikumar P.S.; Therapeutic role of coumarins and coumarin-related compounds. J Thermodyn Catal 2014,5,130-133","journal-title":"J Thermodyn Catal"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"00438","DOI":"10.1128\/AEM.00438-17","volume":"83","author":"Popp D.","year":"2017","unstructured":"Popp D.; Plugge C.M.; Kleinsteuber S.; Harms H.; Str\u00e4uber H.; Inhibitory effect of coumarin on syntrophic fatty acid-oxidizing and methanogen-IC cultures and biogas reactor microbiomes. Appl Environ Microbiol 2017,83(13),00438-17","journal-title":"Appl Environ Microbiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.21307\/ane-2019-011","volume":"79","author":"Bryda J.","year":"2019","unstructured":"Bryda J.; Zagaja M.; Szewczyk A.; Andres-Mach M.; Coumarins as potential supportive medication for the treatment of epilepsy. Acta Neurobiol Exp (Warsz) 2019,79(2),126-132","journal-title":"Acta Neurobiol Exp (Warsz)"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3389\/fmicb.2019.00911","volume":"10","author":"Othman L.","year":"2019","unstructured":"Othman L.; Sleiman A.; Abdel-Massih R.M.; Antimicrobial activity of polyphenols and alkaloids in middle eastern plants. Front Microbiol 2019,10,911","journal-title":"Front Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1021\/np070295v","volume":"70","author":"Curir P.","year":"2007","unstructured":"Curir P.; Galeotti F.; Dolci M.; Barile E.; Lanzotti V.; Pavietin, a coumarin from Aesculus pavia with antifungal activity. J Nat Prod 2007,70(10),1668-1671","journal-title":"J Nat Prod"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1021\/np030373o","volume":"67","author":"Lee K.H.","year":"2004","unstructured":"Lee K.H.; Current developments in the discovery and design of new drug candidates from plant natural product leads. J Nat Prod 2004,67(2),273-283","journal-title":"J Nat Prod"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"7362","DOI":"10.1016\/j.bmc.2009.08.031","volume":"17","author":"Xu J.","year":"2009","unstructured":"Xu J.; Kjer J.; Sendker J.; Wray V.; Guan H.; Edrada R.; M\u00fcller W.E.G.; Bayer M.; Lin W.; Wu J.; Proksch P.; Cytosporones, coumarins, and an alkaloid from the endophytic fungus Pestalotiopsis sp. isolated from the Chinese mangrove plant Rhizophora mucronata. Bioorg Med Chem 2009,17(20),7362-7367","journal-title":"Bioorg Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.2174\/1381612043382710","volume":"10","author":"Fylaktakidou K.C.","year":"2004","unstructured":"Fylaktakidou K.C.; Hadjipavlou-Litina D.J.; Litinas K.E.; Nicolaides D.N.; Natural and synthetic coumarin derivatives with anti-inflammatory\/antioxidant activities. Curr Pharm Des 2004,10(30),3813-3833","journal-title":"Curr Pharm Des"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.3390\/molecules14114790","volume":"14","author":"Jung J.C.","year":"2009","unstructured":"Jung J.C.; Park O.S.; Synthetic approaches and biological activities of 4-hydroxycoumarin derivatives. Molecules 2009,14,4790-4803","journal-title":"Molecules"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"9259","DOI":"10.1016\/j.tetlet.2003.10.076","volume":"44","author":"Musicki B.","year":"2003","unstructured":"Musicki B.; Periers A.M.; Piombo L.; Laurin P.; Klich M.; Dupuis- Hamelin, C.; Lassaigne, P.; Bonnefoy, A. Noviose mimics of the coumarin inhibitors of gyrase B. Tetrahedron Lett 2003,44,9259-9262","journal-title":"Tetrahedron Lett"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"24481","DOI":"10.1016\/S0021-9258(20)80551-1","volume":"268","author":"Peng H.","year":"1993","unstructured":"Peng H.; Marians K.J.; Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions. J Biol Chem 1993,268(32),24481-24490","journal-title":"J Biol Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1021\/jm801496u","volume":"52","author":"Chimenti F.","year":"2009","unstructured":"Chimenti F.; Secci D.; Bolasco A.; Chimenti P.; Bizzarri B.; Granese A.; Carradori S.; Y\u00e1\u00f1ez M.; Orallo F.; Ortuso F.; Alcaro S.; Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J Med Chem 2009,52(7),1935-1942","journal-title":"J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.bmc.2011.12.042","volume":"20","author":"Anand P.","year":"2012","unstructured":"Anand P.; Singh B.; Singh N.; A review on coumarins as acetylcholinesterase inhibitors for Alzheimer\u2019s disease. Bioorg Med Chem 2012,20(3),1175-1180","journal-title":"Bioorg Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2174\/157018011797200768","volume":"8","author":"Noolvi M.N.","year":"2011","unstructured":"Noolvi M.N.; Patel H.M.; Kaur T.A.; QSAR analysis of coumarin derivatives as TNF-inhibitor-A rational approach to anticancer drug design. Lett Drug Des Discov 2011,8,868-876","journal-title":"Lett Drug Des Discov"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.bmcl.2007.12.004","volume":"18","author":"Beillerot A.","year":"2008","unstructured":"Beillerot A.; Dom\u00ednguez J.C.R.; Kirsch G.; Bagrel D.; Synthesis and protective effects of coumarin derivatives against oxidative stress induced by doxorubicin. Bioorg Med Chem Lett 2008,18(3),1102-1105","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1021\/jm000386o","volume":"44","author":"Orita M.","year":"2001","unstructured":"Orita M.; Yamamoto S.; Katayama N.; Aoki M.; Takayama K.; Yamagiwa Y.; Seki N.; Suzuki H.; Kurihara H.; Sakashita H.; Takeuchi M.; Fujita S.; Yamada T.; Tanaka A.; Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: Discovery and X-ray crystallography. J Med Chem 2001,44(4),540-547","journal-title":"J Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1021\/jm070909t","volume":"51","author":"Chilin A.","year":"2008","unstructured":"Chilin A.; Battistutta R.; Bortolato A.; Cozza G.; Zanatta S.; Poletto G.; Mazzorana M.; Zagotto G.; Uriarte E.; Guiotto A.; Pinna L.A.; Meggio F.; Moro S.; Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships. J Med Chem 2008,51(4),752-759","journal-title":"J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.bmc.2004.12.013","volume":"13","author":"Kumar S.","year":"2005","unstructured":"Kumar S.; Singh B.K.; Kalra N.; Kumar V.; Kumar A.; Prasad A.K.; Raj H.G.; Parmar V.S.; Ghosh B.; Novel thiocoumarins as inhibitors of TNF-alpha induced ICAM-1 expression on Human Umbilical Vein Endothelial Cells (HUVECs) and microsomal lipid peroxidation. Bioorg Med Chem 2005,13(5),1605-1613","journal-title":"Bioorg Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jhet.5570420216","volume":"42","author":"Reddy P.V.K.","year":"2005","unstructured":"Reddy P.V.K.; Kumar P.N.; Chandramouli G.V.P.; Synthesis and antimicrobial activity of 6, 60-arylidene-bis-[5-hydroxy-9-methyl-2, 3-diaryl thieno[3, 2-g-]thiocoumarins J Heterocycl Chem 2005,42,283-286","journal-title":"J Heterocycl Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00044-015-1350-8","volume":"24","author":"Barot K.P.","year":"2015","unstructured":"Barot K.P.; Jain S.V.; Kremer L.; Recent advances and therapeutic journey of coumarins: Current status and perspectives. Med Chem Res 2015,24,2771-2798","journal-title":"Med Chem Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/187152307783219989","volume":"6","author":"Hadjipavlou-Litina D.J.","year":"2007","unstructured":"Hadjipavlou-Litina D.J.; Litinas K.E.; Kontogiorgis C.; The anti-inflammatory effect of coumarin and its derivatives. Antiinflamm Antiallergy Agents Med Chem 2007,6(4),293-306","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jff.2014.12.004","volume":"12","author":"Kim Y.","year":"2015","unstructured":"Kim Y.; Lee J.; Esculetin, a coumarin derivative, suppresses adipogenesis through modulation of the AMPK pathway in 3T3-L1 adipocytes. J Funct Foods 2015,12,509-515","journal-title":"J Funct Foods"},{"key":"ref=28","first-page":"86","volume":"16","author":"Hod\u00e1k K.","year":"1967","unstructured":"Hod\u00e1k K.; Jakesov\u00e1 V.; Dad\u00e1k V.; On the antibiotic effects of natural coumarins. VI. The relation of structure to the antibacterial effects of some natural coumarins and the neutralization of such effects. Cesk Farm 1967,16(2),86-91","journal-title":"Cesk Farm"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1055\/s-2003-38876","volume":"69","author":"Schinkovitz A.","year":"2003","unstructured":"Schinkovitz A.; Gibbons S.; Stavri M.; Cocksedge M.J.; Bucar F.; Ostruthin: An antimycobacterial coumarin from the roots of Peucedanum ostruthium. Planta Med 2003,69(4),369-371","journal-title":"Planta Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"15529","DOI":"10.1021\/ja065793p","volume":"128","author":"Burlison J.A.","year":"2006","unstructured":"Burlison J.A.; Neckers L.; Smith A.B.; Maxwell A.; Blagg B.S.; Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90. J Am Chem Soc 2006,128(48),15529-15536","journal-title":"J Am Chem Soc"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1128\/AAC.25.6.687","volume":"25","author":"Neu H.C.","year":"1984","unstructured":"Neu H.C.; Chin N.X.; Labthavikul P.; Antibacterial activity of coumermycin alone and in combination with other antibiotics. Antimicrob Agents Chemother 1984,25(6),687-689","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.chembiol.2005.04.017","volume":"12","author":"Xu Z.","year":"2005","unstructured":"Xu Z.; Jakobi K.; Welzel K.; Hertweck C.; Biosynthesis of the antitumor agent chartreusin involves the oxidative rearrangement of an anthracyclic polyketide. Chem Biol 2005,12(5),579-588","journal-title":"Chem Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1517\/13543776.2012.678835","volume":"22","author":"Kontogiorgis C.","year":"2012","unstructured":"Kontogiorgis C.; Detsi A.; Hadjipavlou-Litina D.; Coumarin-based drugs: A patent review (2008 -- present). Expert Opin Ther Pat 2012,22(4),437-454","journal-title":"Expert Opin Ther Pat"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1159\/000331641","volume":"57","author":"Luo K.W.","year":"2011","unstructured":"Luo K.W.; Sun J.G.; Chan J.Y.; Yang L.; Wu S.H.; Fung K.P.; Liu F.Y.; Anticancer effects of imperatorin isolated from Angelica dahurica: Induction of apoptosis in HepG2 cells through both death-receptor- and mitochondria-mediated pathways. Chemotherapy 2011,57(6),449-459","journal-title":"Chemotherapy"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3390\/molecules22101672","volume":"22","author":"Yu X.","year":"2017","unstructured":"Yu X.; Wen Y.; Liang C-G.; Liu J.; Ding Y-B.; Zhang W-H.; Design, synthesis and antifungal activity of psoralen derivatives. Molecules 2017,22(10),1672","journal-title":"Molecules"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2478\/s11756-019-00242-x","volume":"74","author":"Hussain M.I.","year":"2019","unstructured":"Hussain M.I.; Syed Q.A.; Khattak M.N.K.; Natural product coumarins: Biological and pharmacological perspectives. Biologia 2019,74,863-888","journal-title":"Biologia"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/00498254.2018.1434913","volume":"49","author":"Palacharla R.C.","year":"2019","unstructured":"Palacharla R.C.; Molgara P.; Panthangi H.R.; Boggavarapu R.K.; Manoharan A.K.; Ponnamaneni R.K.; Ajjala D.R.; Nirogi R.; Methoxsalen as an in vitro phenotyping tool in comparison with 1-aminobenzotriazole. Xenobiotica 2019,49(2),169-176","journal-title":"Xenobiotica"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.15586\/qas.v12i2.627","volume":"12","author":"Sava\u015f E.","year":"2020","unstructured":"Sava\u015f E.; Tav\u015fanl\u0131 H.; Catalkaya G.; Capanoglu E.; Tamer C.; The antimicrobial and antioxidant properties of garagurt: Traditional Cornelian cherry (Cornus mas) marmalade. Qual Assur Saf Crops Foods 2020,12,12-23","journal-title":"Qual Assur Saf Crops Foods"},{"key":"ref=39","first-page":"15","volume":"2019","author":"Tkachenko H.","year":"2016","unstructured":"Tkachenko H.; Buyun L.; Terech-Majewska E.; Osadowski Z.; Sosnovsky E.; Honcharenko V.; Prokopiv A.; In vitro antibacterial efficacy of various ethanolic extracts obtained from Ficus spp. leaves against fish pathogen, Pseudomonas fluorescens. Arch Pol Fisheries 2016,2019(27),15-26","journal-title":"Arch Pol Fisheries"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/cbdv.200900326","volume":"7","author":"Chiang C-C.","year":"2010","unstructured":"Chiang C-C.; Cheng M-J.; Peng C-F.; Huang H-Y.; Chen I.S.; A novel dimeric coumarin analog and antimycobacterial constituents from Fatoua pilosa. Chem Biodivers 2010,7(7),1728-1736","journal-title":"Chem Biodivers"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/molecules14030939","volume":"14","author":"Basile A.","year":"2009","unstructured":"Basile A.; Sorbo S.; Spadaro V.; Bruno M.; Maggio A.; Faraone N.; Rosselli S.; Antimicrobial and antioxidant activities of coumarins from the roots of Ferulago campestris (Apiaceae). Molecules 2009,14(3),939-952","journal-title":"Molecules"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/0929867053507315","volume":"12","author":"Borges F.","year":"2005","unstructured":"Borges F.; Roleira F.; Milhazes N.; Santana L.; Uriarte E.; Simple coumarins and analogues in medicinal chemistry: Occurrence, synthesis and biological activity. Curr Med Chem 2005,12(8),887-916","journal-title":"Curr Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/molecules24081620","volume":"24","author":"Foroozesh M.","year":"2019","unstructured":"Foroozesh M.; Sridhar J.; Goyal N.; Liu J.; Coumarins and P450s, studies reported to-date. Molecules 2019,24(8),1620","journal-title":"Molecules"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.tiv.2005.08.001","volume":"20","author":"Lewis D.F.V.","year":"2006","unstructured":"Lewis D.F.V.; Ito Y.; Lake B.G.; Metabolism of coumarin by human P450s: a molecular modelling study. Toxicol In Vitro 2006,20(2),256-264","journal-title":"Toxicol In Vitro"},{"key":"ref=45","first-page":"2093","volume":"17","author":"Jayashree B.S.","year":"2005","unstructured":"Jayashree B.S.; Anuradha D.; Venugopala K.N.; Synthesis and characterization of schiff bases of 2\u2032-amino-4\u2032-(6-chloro-3- coumarinyl)-thiazole as potential NSAIDs. Asian J Chem 2005,17,2093-2097","journal-title":"Asian J Chem"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5530\/srp.2017.1.11","volume":"8","author":"Al-Majedy Yasameen K.","year":"2017","unstructured":"Al-Majedy Yasameen K.; Abdul Amir H.; Kadhum, Ahmed A.; Al-Amiery.; and Abu Bakar Mohamad. Coumarins: the antimicrobial agents. Syst Rev Pharm 2017,8,62","journal-title":"Syst Rev Pharm"},{"key":"ref=47","first-page":"2495","volume":"4","author":"Behrami A.","year":"2012","unstructured":"Behrami A.; Krasniqi I.; Antibacterial activity of coumarine derivatives synthesized from 8- amino4,7-dihydroxy-chromen-2-one and comparison with standard drug. J Chem Pharm 2012,4,2495-2500","journal-title":"J Chem Pharm"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13756-019-0559-6","volume":"8","author":"Khameneh B.","year":"2019","unstructured":"Khameneh B.; Iranshahy M.; Soheili V.; Fazly Bazzaz B.S.; Review on plant antimicrobials: a mechanistic viewpoint. Antimicrob Resist Infect Control 2019,8,118","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"112013","DOI":"10.1016\/j.ejmech.2019.112013","volume":"189","author":"Xu X.T.","year":"2020","unstructured":"Xu X.T.; Deng X.Y.; Chen J.; Liang Q.M.; Zhang K.; Li D.L.; Wu P.P.; Zheng X.; Zhou R.P.; Jiang Z.Y.; Ma A.J.; Chen W.H.; Wang S.H.; Synthesis and biological evaluation of coumarin derivatives as \u03b1-glucosidase inhibitors. Eur J Med Chem 2020,189,112013","journal-title":"Eur J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1016\/j.bmc.2005.02.051","volume":"13","author":"Reddy N.S.","year":"2005","unstructured":"Reddy N.S.; Gumireddy K.; Mallireddigari M.R.; Cosenza S.C.; Venkatapuram P.; Bell S.C.; Reddy E.P.; Reddy M.V.; Novel coumarin-3-(N-aryl)carboxamides arrest breast cancer cell growth by inhibiting ErbB-2 and ERK1. Bioorg Med Chem 2005,13(9),3141-3147","journal-title":"Bioorg Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bioorg.2018.12.040","volume":"85","author":"Mohamed T.K.","year":"2019","unstructured":"Mohamed T.K.; Batran R.Z.; Elseginy S.A.; Ali M.M.; Mahmoud A.E.; Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis. Bioorg Chem 2019,85,253-273","journal-title":"Bioorg Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/14756360500323022","volume":"21","author":"Kontogiorgis C.A.","year":"2006","unstructured":"Kontogiorgis C.A.; Savvoglou K.; Hadjipavlou L.D.J.; Evaluation of natural substances from Evolvulusalsinoides L. with the purpose of determining their antioxidant potency. J Enzyme Inhib Med Chem 2006,21,21-29","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/1475636031000069291","volume":"18","author":"Kontogiorgis C.","year":"2003","unstructured":"Kontogiorgis C.; Hadjipavlou-Litina D.; Biological evaluation of several coumarin derivatives designed as possible anti-inflammatory\/antioxidant agents. J Enzyme Inhib Med Chem 2003,18(1),63-69","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1039\/b103092m","volume":"1","author":"Fylaktakidou K.C.","year":"2001","unstructured":"Fylaktakidou K.C.; Gautam D.; Hadjipavlou-Litina D.; Kontogiorgis C.; Litinas K.; Nicolaides D.; Reactions of 4- methylchromene-2,7,8-trionewith phosphonium ylides. Synthesis and evaluation of fused 1,3-dioxolaneocoumarins as antioxidants and antiinflammatories. J Chem Soc Perkin Trans 2001,1,3073-3079","journal-title":"J Chem Soc Perkin Trans"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jhet.5570410421","volume":"41","author":"Nicolaides D.","year":"2004","unstructured":"Nicolaides D.; Gautam D.; Litinas K.; Hadjipavlou-Litina D.; Kontogiorgis C.; Synthesis and biological evaluation of Benzo[7,8]chromeno[5,6-b][1,4]oxazin-3-ones. J Heterocycl Chem 2004,41,605-611","journal-title":"J Heterocycl Chem"},{"key":"ref=56","first-page":"3577","volume":"5","author":"Kayal G.","year":"2014","unstructured":"Kayal G.; Jain K.; Malviya S.; Kharia. A: Comparative SAR of synthetic coumarin derivatives for their anti-inflammatory activity. Int J Pharm Sci Res 2014,5,3577-3583","journal-title":"Int J Pharm Sci Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.ejmech.2007.08.007","volume":"43","author":"Kalkhambkar R.G.","year":"2008","unstructured":"Kalkhambkar R.G.; Kulkarni G.M.; Kamanavalli C.M.; Premkumar N.; Asdaq S.M.B.; Sun C.M.; Synthesis and biological activities of some new fluorinated coumarins and 1-aza coumarins. Eur J Med Chem 2008,43(10),2178-2188","journal-title":"Eur J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/1568026618666171215101158","volume":"18","author":"Hu X-L.","year":"2018","unstructured":"Hu X-L.; Gao C.; Xu Z.; Liu M.L.; Feng L.S.; Zhang G-D.; Recent development of coumarin derivatives as potential antiplasmodial and antimalarial agents. Curr Top Med Chem 2018,18(2),114-123","journal-title":"Curr Top Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejmech.2014.07.087","volume":"85","author":"Pingaew R.","year":"2014","unstructured":"Pingaew R.; Saekee A.; Mandi P.; Nantasenamat C.; Prachayasittikul S.; Ruchirawat S.; Prachayasittikul V.; Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents. Eur J Med Chem 2014,85,65-76","journal-title":"Eur J Med Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3844\/ajptsp.2014.132.138","volume":"9","author":"Arshad M.F.","year":"2014","unstructured":"Arshad M.F.; Siddiqui N.; Elkerdasy A.; Al Rohaimi A.H.; Khan S.A.; Anticonvulsant and neurotoxicity evaluation of some newly synthesized thiazolyl coumarin derivatives. Am J Pharmacol Toxicol 2014,9,132","journal-title":"Am J Pharmacol Toxicol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.eplepsyres.2009.03.027","volume":"85","author":"Luszczki J.J.","year":"2009","unstructured":"Luszczki J.J.; Wojda E.; Andres-Mach M.; Cisowski W.; Glensk M.; Glowniak K.; Czuczwar S.J.; Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: A comparative study. Epilepsy Res 2009,85(2-3),293-299","journal-title":"Epilepsy Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1016\/j.bmcl.2006.06.007","volume":"16","author":"Lee S.","year":"2006","unstructured":"Lee S.; Sivakumar K.; Shin W.S.; Xie F.; Wang Q.; Synthesis and anti-angiogenesis activity of coumarin derivatives. Bioorg Med Chem Lett 2006,16(17),4596-4599","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=63","first-page":"120","volume":"10","author":"Sharma A.","year":"2018","unstructured":"Sharma A.; Gupta Monika; Synthesis and biological evaluation of coumarin as derivative antiproliferatives agents J Chem Pharm Res 2018,10,120-132","journal-title":"J Chem Pharm Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.bmcl.2008.03.003","volume":"18","author":"Dwivedi A.P.","year":"2008","unstructured":"Dwivedi A.P.; Kumar S.; Varshney V.; Singh A.B.; Srivastava A.K.; Sahu D.P.; Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines. Bioorg Med Chem Lett 2008,18(7),2301-2305","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1001\/jama.288.2.222","volume":"288","author":"Yeni P.G.","year":"2002","unstructured":"Yeni P.G.; Hammer S.M.; Carpenter C.C.; Cooper D.A.; Fischl M.A.; Gatell J.M.; Gazzard B.G.; Hirsch M.S.; Jacobsen D.M.; Katzenstein D.A.; Montaner J.S.; Richman D.D.; Saag M.S.; Schechter M.; Schooley R.T.; Thompson M.A.; Vella S.; Volberding P.A.; Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA Panel. JAMA 2002,288(2),222-235","journal-title":"JAMA"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.antiviral.2005.02.006","volume":"66","author":"M\u00e1rquez N.","year":"2005","unstructured":"M\u00e1rquez N.; Sancho R.; Bedoya L.M.; Alcam\u00ed J.; L\u00f3pez-P\u00e9rez J.L.; Feliciano A.S.; Fiebich B.L.; Mu\u00f1oz E.; Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway. Antiviral Res 2005,66(2-3),137-145","journal-title":"Antiviral Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/med.10034","volume":"23","author":"Yu D.","year":"2003","unstructured":"Yu D.; Suzuki M.; Xie L.; Morris-Natschke S.L.; Lee K.H.; Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Med Res Rev 2003,23(3),322-345","journal-title":"Med Res Rev"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0014-827X(02)01264-8","volume":"57","author":"Kirkiacharian S.","year":"2002","unstructured":"Kirkiacharian S.; Thuy D.T.; Sicsic S.; Bakhchinian R.; Kurkjian R.; Tonnaire T.; Structure-activity relationships of some 3-substituted-4-hydroxycoumarins as HIV-1 protease inhibitors. Farmaco 2002,57(9),703-708","journal-title":"Farmaco"},{"key":"ref=69","author":"Lyndem S.","year":"2020","unstructured":"Lyndem S.; Sarmah S.; Das S.; Singha, Roy. A. In silico screening of naturally occurring coumarin derivatives for the inhibition of the main protease of SARS-CoV-2 ChemRxiv 2020","journal-title":"ChemRxiv"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1021\/cr050521a","volume":"105","author":"Chen F.E.","year":"2005","unstructured":"Chen F.E.; Huang J.; Reserpine: A challenge for total synthesis of natural products. Chem Rev 2005,105(12),4671-4706","journal-title":"Chem Rev"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"10012","DOI":"10.1073\/pnas.0403596101","volume":"101","author":"Wu C.Y.","year":"2004","unstructured":"Wu C.Y.; Jan J.T.; Ma S.H.; Kuo C.J.; Juan H.F.; Cheng Y.S.; Hsu H.H.; Huang H.C.; Wu D.; Brik A.; Liang F.S.; Liu R.S.; Fang J.M.; Chen S.T.; Liang P.H.; Wong C.H.; Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci USA 2004,101(27),10012-10017","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/10286020500382397","volume":"9","author":"Yang Q.Y.","year":"2007","unstructured":"Yang Q.Y.; Tian X.Y.; Fang W.S.; Bioactive coumarins from Boenninghausenia sessilicarpa. J Asian Nat Prod Res 2007,9(1),59-65","journal-title":"J Asian Nat Prod Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.antiviral.2005.02.007","volume":"67","author":"Li S.Y.","year":"2005","unstructured":"Li S.Y.; Chen C.; Zhang H.Q.; Guo H.Y.; Wang H.; Wang L.; Zhang X.; Hua S.N.; Yu J.; Xiao P.G.; Li R.S.; Tan X.; Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005,67(1),18-23","journal-title":"Antiviral Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ijantimicag.2018.05.003","volume":"52","author":"Kim J.Y.","year":"2018","unstructured":"Kim J.Y.; Kim Y.I.; Park S.J.; Kim I.K.; Choi Y.K.; Kim S.H.; Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein. Int J Antimicrob Agents 2018,52(5),730-732","journal-title":"Int J Antimicrob Agents"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1440-1681.2006.04415.x","volume":"33","author":"Cheng P.W.","year":"2006","unstructured":"Cheng P.W.; Ng L.T.; Chiang L.C.; Lin C.C.; Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin Exp Pharmacol Physiol 2006,33(7),612-616","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/biom9110696","volume":"9","author":"Kim D.E.","year":"2019","unstructured":"Kim D.E.; Min J.S.; Jang M.S.; Lee J.Y.; Shin Y.S.; Song J.H.; Kim H.R.; Kim S.; Jin Y.H.; Kwon S.; Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells. Biomolecules 2019,9(11),696","journal-title":"Biomolecules"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/BF02980198","volume":"26","author":"Jeong C.S.","year":"2003","unstructured":"Jeong C.S.; Hyun J.E.; Kim Y.S.; Ginsenoside Rb1: The anti-ulcer constituent from the head of Panax ginseng. Arch Pharm Res 2003,26(11),906-911","journal-title":"Arch Pharm Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.apsb.2020.06.002","volume":"10","author":"Xian Y.","year":"2020","unstructured":"Xian Y.; Zhang J.; Bian Z.; Zhou H.; Zhang Z.; Lin Z.; Xu H.; Bioactive natural compounds against human coronaviruses: A review and perspective. Acta Pharm Sin B 2020,10(7),1163-1174","journal-title":"Acta Pharm Sin B"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","volume":"26","author":"Tortorici M.A.","year":"2019","unstructured":"Tortorici M.A.; Walls A.C.; Lang Y.; Wang C.; Li Z.; Koerhuis D.; Boons G.J.; Bosch B.J.; Rey F.A.; de Groot R.J.; Veesler D.; Structural basis for human coronavirus attachment to sialic acid receptors. Nat Struct Mol Biol 2019,26(6),481-489","journal-title":"Nat Struct Mol Biol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.aivir.2016.08.004","volume":"96","author":"Hulswit R.J.","year":"2016","unstructured":"Hulswit R.J.; de Haan C.A.; Bosch B.J.de; Haan C.A.; Bosch B.J.; Coronavirus spike protein and tropism changes. Adv Virus Res 2016,96,29-57","journal-title":"Adv Virus Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1038\/emm.2015.76","volume":"47","author":"Durai P.","year":"2015","unstructured":"Durai P.; Batool M.; Shah M.; Choi S.; Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control. Exp Mol Med 2015,47,e181","journal-title":"Exp Mol Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"e1004113","DOI":"10.1371\/journal.ppat.1004113","volume":"10","author":"Ratia K.","year":"2014","unstructured":"Ratia K.; Kilianski A.; Baez-Santos Y.M.; Baker S.C.; Mesecar A.; Structural basis for the ubiquitin-linkage specificity and deISGylating activity of SARS-CoV papain-like protease. PLoS Pathog 2014,10(5),e1004113","journal-title":"PLoS Pathog"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1128\/JVI.79.7.4550-4551.2005","volume":"79","author":"Sulea T.","year":"2005","unstructured":"Sulea T.; Lindner H.A.; Purisima E.O.; M\u00e9nard R.; Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain-like protease? J Virol 2005,79(7),4550-4551","journal-title":"J Virol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","volume":"115","author":"B\u00e1ez-Santos Y.M.","year":"2015","unstructured":"B\u00e1ez-Santos Y.M.; St John S.E.; Mesecar A.D.; The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. Antiviral Res 2015,115,21-38","journal-title":"Antiviral Res"},{"key":"ref=85","first-page":"1","volume":"2019","author":"Ganeshpurkar A.","year":"2019","unstructured":"Ganeshpurkar A.; Gutti G.; Singh S.K.; RNA-dependent RNA polymerases and their emerging roles in antiviral therapy. Viral polymerases: Structures, functions, and roles as antiviral drug targets. Eur J Med Chem 2019,2019,1-42","journal-title":"Eur J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0166-3542(93)90094-Y","volume":"22","author":"Kurokawa M.","year":"1993","unstructured":"Kurokawa M.; Ochiai H.; Nagasaka K.; Neki M.; Xu H.; Kadota S.; Sutardjo S.; Matsumoto T.; Namba T.; Shiraki K.; Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res 1993,22(2-3),175-188","journal-title":"Antiviral Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.3390\/v4102197","volume":"4","author":"Calland N.","year":"2012","unstructured":"Calland N.; Dubuisson J.; Rouill\u00e9 Y.; S\u00e9ron K.; Hepatitis C virus and natural compounds: A new antiviral approach? Viruses 2012,4(10),2197-2217","journal-title":"Viruses"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0031-9422(02)00753-7","volume":"62","author":"Du J.","year":"2003","unstructured":"Du J.; He Z.D.; Jiang R.W.; Ye W.C.; Xu H.X.; But P.P.; Antiviral flavonoids from the root bark of Morus alba L. Phytochemistry 2003,62(8),1235-1238","journal-title":"Phytochemistry"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0166-3542(99)00053-4","volume":"44","author":"Xu H.X.","year":"1999","unstructured":"Xu H.X.; Lee S.H.; Lee S.F.; White R.L.; Blay J.; Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris. Antiviral Res 1999,44(1),43-54","journal-title":"Antiviral Res"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3987\/COM-93-6550","volume":"38","author":"Xu H.X.","year":"1994","unstructured":"Xu H.X.; Kadota S.; Wang H.; Kurokawa M.; Shiraki K.; Matsumoto T.; A new hydrolyzable tannin from Geum japonicum and its antiviral activity. Heterocycles 1994,38,167-175","journal-title":"Heterocycles"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1248\/cpb.41.1803","volume":"41","author":"Xu H.X.","year":"1993","unstructured":"Xu H.X.; Kadota S.; Kurokawa M.; Shiraki K.; Matsumoto T.; Namba T.; Isolation and structure of woodorien, a new glucoside having antiviral activity, from Woodwardia orientalis. Chem Pharm Bull (Tokyo) 1993,41(10),1803-1806","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.compbiolchem.2017.11.001","volume":"71","author":"Kannan S.","year":"2017","unstructured":"Kannan S.; Kolandaivel P.; Antiviral potential of natural compounds against influenza virus hemagglutinin. Comput Biol Chem 2017,71,207-218","journal-title":"Comput Biol Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3389\/fmicb.2018.01826","volume":"9","author":"Luganini A.","year":"2018","unstructured":"Luganini A.; Terlizzi M.E.; Catucci G.; Gilardi G.; Maffei M.E.; Gribaudo G.; The cranberry extract oximacro\u00ae exerts in vitro virucidal activity against influenza virus by interfering with hemagglutinin. Front Microbiol 2018,9,1826","journal-title":"Front Microbiol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1021\/np960165e","volume":"59","author":"Xu H.X.","year":"1996","unstructured":"Xu H.X.; Zeng F.Q.; Wan M.; Sim K.Y.; Anti-HIV triterpene acids from Geum japonicum. J Nat Prod 1996,59(7),643-645","journal-title":"J Nat Prod"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1248\/cpb.48.1367","volume":"48","author":"Xu H.X.","year":"2000","unstructured":"Xu H.X.; Ming D.S.; Dong H.; But P.P.; A new anti-HIV triterpene from Geum japonicum. Chem Pharm Bull (Tokyo) 2000,48(9),1367-1369","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/(SICI)1099-1573(199605)10:3<207:AID-PTR812>3.0.CO;2-U","volume":"10","author":"Xu H.X.","year":"1996","unstructured":"Xu H.X.; Wan M.; Loh B.N.; Kon O.L.; Chow P.W.; Sim K.Y.; Screening of traditional medicines for their inhibitory activity against HIV-1 protease. Phytother Res 1996,10,207-210","journal-title":"Phytother Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"e02009","DOI":"10.1128\/JVI.02009-18","volume":"93","author":"Sahuc M.E.","year":"2019","unstructured":"Sahuc M.E.; Sahli R.; Rivi\u00e8re C.; P\u00e8ne V.; Lavie M.; Vandeputte A.; Brodin P.; Rosenberg A.R.; Dubuisson J.; Ksouri R.; Rouill\u00e9 Y.; Sahpaz S.; S\u00e9ron K.; Dehydrojuncusol, a natural phenanthrene compound extracted from Juncusmaritimus, is a new inhibitor of hepatitis C virus RNA replication. J Virol 2019,93(10),e02009-e02018","journal-title":"J Virol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1021\/acs.jnatprod.8b00576","volume":"81","author":"Zhang Y.B.","year":"2018","unstructured":"Zhang Y.B.; Luo D.; Yang L.; Cheng W.; He L.J.; Kuang G.K.; Li M.M.; Li Y.L.; Wang G.C.; Matrine-type alkaloids from the roots of Sophora flavescens and their antiviral activities against the hepatitis B virus. J Nat Prod 2018,81(10),2259-2265","journal-title":"J Nat Prod"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bmc.2018.12.038","volume":"27","author":"Li B.","year":"2019","unstructured":"Li B.; Li L.; Peng Z.; Liu D.; Si L.; Wang J.; Yuan B.; Huang J.; Proksch P.; Lin W.; Harzianoic acids A and B, new natural scaffolds with inhibitory effects against hepatitis C virus. Bioorg Med Chem 2019,27(3),560-567","journal-title":"Bioorg Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","volume":"361","author":"Cinatl J.","year":"2003","unstructured":"Cinatl J.; Morgenstern B.; Bauer G.; Chandra P.; Rabenau H.; Doerr H.W.; Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003,361(9374),2045-2046","journal-title":"Lancet"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12879-017-2253-8","volume":"17","author":"Lin S.C.","year":"2017","unstructured":"Lin S.C.; Ho C.T.; Chuo W.H.; Li S.; Wang T.T.; Lin C.C.; Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect Dis 2017,17(1),144","journal-title":"BMC Infect Dis"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.3390\/ijms21093099","volume":"21","author":"Bz\u00f3wka M.","year":"2020","unstructured":"Bz\u00f3wka M.; Mitusi\u0144ska K.; Raczy\u0144ska A.; Samol A.; Tuszy\u0144ski J.A.; G\u00f3ra A.; Structural and evolutionary analysis indicate that the SARS-COV-2 MPRO is a challenging target for small-molecule inhibitor design. Int J Mol Sci 2020,21(9),3099","journal-title":"Int J Mol Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","volume":"19","author":"Li G.","year":"2020","unstructured":"Li G.; De Clercq E.; Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020,19(3),149-150","journal-title":"Nat Rev Drug Discov"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/cbic.202000047","volume":"21","author":"Morse J.S.","year":"2020","unstructured":"Morse J.S.; Lalonde T.; Xu S.; Liu W.R.; Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. ChemBioChem 2020,21(5),730-738","journal-title":"ChemBioChem"},{"key":"ref=105","first-page":"13140","volume":"10","author":"Khan T.","year":"2020","unstructured":"Khan T.; Khan M.; Plant in vitro culture technologies; a promise into factories of secondary metabolites against COVID-19. Front Plant Sci 2020,10,13140","journal-title":"Front Plant Sci"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.apsb.2020.06.002","volume":"10","author":"Yanfang X.","year":"2020","unstructured":"Yanfang X.; Juan, Zhang.; Zhaoxiang, Bian.; Hua, Zhou.; Zhenbiao, Zhang.; Zhixiu, Lin.; Hongxi, Xu. Bioactive natural compounds against human coronaviruses: A review and perspective. Acta Pharm Sin B 2020,10,1163-1174","journal-title":"Acta Pharm Sin B"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.antiviral.2006.04.014","volume":"74","author":"Ho T.Y.","year":"2007","unstructured":"Ho T.Y.; Wu S.L.; Chen J.C.; Li C.C.; Hsiang C.Y.; Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res 2007,74(2),92-101","journal-title":"Antiviral Res"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"104859","DOI":"10.1016\/j.phrs.2020.104859","volume":"157","author":"McKee D.L.","year":"2020","unstructured":"McKee D.L.; Sternberg A.; Stange U.; Laufer S.; Naujokat C.; Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacol Res 2020,157,104859","journal-title":"Pharmacol Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"153286","DOI":"10.1016\/j.phymed.2020.153286","volume":"85","author":"Mhatre S.","year":"2021","unstructured":"Mhatre S.; Srivastava T.; Naik S.; Patravale V.; Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review. Phytomedicine 2021,85,153286","journal-title":"Phytomedicine"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/14756366.2014.1003215","volume":"31","author":"Park J.Y.","year":"2016","unstructured":"Park J.Y.; Ko J.A.; Kim D.W.; Kim Y.M.; Kwon H.J.; Jeong H.J.; Kim C.Y.; Park K.H.; Lee W.S.; Ryu Y.B.; Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzyme Inhib Med Chem 2016,31(1),23-30","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1177\/1934578X1601100840","volume":"11","author":"Wahyuni T.S.","year":"2016","unstructured":"Wahyuni T.S.; Utsubo C.A.; Hotta H.; Promising anti-hepatitis C virus compounds from natural resources. Nat Prod Commun 2016,11(8),1193-1200","journal-title":"Nat Prod Commun"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.antiviral.2017.06.007","volume":"144","author":"Liu L.","year":"2017","unstructured":"Liu L.; Hu Y.; Shen Y.F.; Wang G.X.; Zhu B.; Evaluation on antiviral activity of coumarin derivatives against spring viraemia of carp virus in epithelioma papulosum cyprini cells. Antiviral Res 2017,144,173-185","journal-title":"Antiviral Res"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.bmcl.2019.05.019","volume":"29","author":"Hu Y.","year":"2019","unstructured":"Hu Y.; Chen W.; Shen Y.; Zhu B.; Wang G.X.; Synthesis and antiviral activity of coumarin derivatives against infectious hematopoietic necrosis virus. Bioorg Med Chem Lett 2019,29(14),1749-1755","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.3390\/molecules17055713","volume":"17","author":"Al-Amiery A.A.","year":"2012","unstructured":"Al-Amiery A.A.; Kadhum A.A.H.; Mohamad A.B.; Antifungal activities of new coumarins. Molecules 2012,17(5),5713-5723","journal-title":"Molecules"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bmcl.2010.07.013","volume":"20","author":"Matos M.","year":"2010","unstructured":"Matos M.; Vina J.; Janeiro D.; Borges P.; Santana F.; Uriarte E.;  Bioorg Med Chem Lett 2010,20,51-57","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=116","first-page":"54","volume":"4","author":"Maja M.","year":"2012","unstructured":"Maja M.; \u010ca\u010di\u0107 C.; Antioxidant activity of some (7-hydroxy-2- oxo-2Hchromen-4yl) acetic acid derivatives. Croat J Food Sci Technol 2012,4,54-63","journal-title":"Croat J Food Sci Technol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00044-017-1820-2","volume":"26","author":"Khan. Yusufzai S.","year":"2017","unstructured":"Khan. Yusufzai S.; Osman, H.; Khan, M.S.; Mohamad, S.; Sulaiman, O.; Parumasivam, T.; Johansah, N. Design, characterization, in vitro antibacterial, antitubercular evaluation and structure-activity relationships of new hydrazinyl thiazolyl coumarin derivatives. Med Chem Res 2017,26,1139-1148","journal-title":"Med Chem Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13065-018-0435-0","volume":"12","author":"Yusufzai S.K.","year":"2018","unstructured":"Yusufzai S.K.; Osman H.; Khan M.S.; Abd Razik B.M.; Ezzat M.O.; Mohamad S.; Sulaiman O.; Gansau J.A.; Parumasivam T.; 4-Thiazolidinone coumarin derivatives as two-component NS2B\/NS3 DENV flavivirus serine protease inhibitors: Synthesis, molecular docking, biological evaluation and structure-activity relationship studies. Chem Cent J 2018,12(1),69","journal-title":"Chem Cent J"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0165-6147(00)01885-X","volume":"23","author":"Gresele P.","year":"2002","unstructured":"Gresele P.; Agnelli G.; Novel approaches to the treatment of thrombosis. Trends Pharmacol Sci 2002,23(1),25-32","journal-title":"Trends Pharmacol Sci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1517\/13543784.16.3.271","volume":"16","author":"Weitz J.I.","year":"2007","unstructured":"Weitz J.I.; Linkins L.A.; Beyond heparin and warfarin: The new generation of anticoagulants. Expert Opin Investig Drugs 2007,16(3),271-282","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=121","first-page":"94","volume":"43","author":"Vacca J.P.","year":"2000","unstructured":"Vacca J.P.; Functional diversity of compound libraries. Curr Opin Chem Biol 2000,43,94","journal-title":"Curr Opin Chem Biol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2174\/0929867043365314","volume":"11","author":"Andronati S.A.","year":"2004","unstructured":"Andronati S.A.; Karaseva T.L.; Krysko A.A.; Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications. Curr Med Chem 2004,11(9),1183-1211","journal-title":"Curr Med Chem"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1021\/jm800180e","volume":"51","author":"Chackalamannil S.","year":"2008","unstructured":"Chackalamannil S.; Wang Y.; Greenlee W.J.; Hu Z.; Xia Y.; Ahn H.S.; Boykow G.; Hsieh Y.; Palamanda J.; Agans-Fantuzzi J.; Kurowski S.; Graziano M.; Chintala M.; Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. J Med Chem 2008,51(11),3061-3064","journal-title":"J Med Chem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1016\/j.bmcl.2012.03.059","volume":"22","author":"Sashidhara K.V.","year":"2012","unstructured":"Sashidhara K.V.; Palnati G.R.; Avula S.R.; Singh S.; Jain M.; Dikshit M.; Synthesis and evaluation of anti-thrombotic activity of benzocoumarin amide derivatives. Bioorg Med Chem Lett 2012,22(9),3115-3121","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557521666211116120823","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197959\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557521666211116120823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T17:12:57Z","timestamp":1661447577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197959\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":124,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557521666211116120823","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}